News
INO
1.160
-2.52%
-0.030
Inovio Pharmaceuticals Inc. Stock Climbs 7.2%, Outperforms Peers
Dow Jones · 1d ago
Weekly Report: what happened at INO last week (0406-0410)?
Weekly Report · 3d ago
Analysts Are Bullish on Top Healthcare Stocks: Inovio Pharmaceuticals (INO), Elevance Health (ELV)
TipRanks · 04/09 11:30
Inovio Pharmaceuticals Inc. Stock Slides 7.1%, Underperforms Peers
Dow Jones · 04/07 20:33
Inovio announces annual shareholder meeting in virtual-only format
Reuters · 04/07 20:13
INO Deadline Today: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit
PR Newswire · 04/07 18:52
What's Going On With Inovio Pharmaceuticals Stock On Tuesday?
Benzinga · 04/07 13:15
Inovio Deadline Today: Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Barchart · 04/07 10:16
INO CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026
Barchart · 04/07 08:54
Inovio: 'Hold' As Upcoming PDUFA For INO-3107 Is Major Inflection Point
Seeking Alpha · 04/06 14:31
Inovio Pharmaceuticals Announces New Public Equity Offering
TipRanks · 04/06 13:20
Inovio plans underwritten stock offering with Series A and B warrants
Reuters · 04/06 11:03
Deadline Soon: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Barchart · 04/06 11:00
Weekly Report: what happened at INO last week (0330-0403)?
Weekly Report · 04/06 09:53
Inovio Pharmaceuticals Inc. Stock Falls 35.1%, Underperforms Peers
Dow Jones · 04/02 20:33
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 04/02 17:05
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
Reuters · 04/02 15:48
What's Behind The Drop In Inovio Pharmaceuticals Stock Today?
Benzinga · 04/02 15:03
Inovio Pharma Shares Hit 52-Week Low After Public Offering Prices
Dow Jones · 04/02 14:54
BUZZ-U.S. STOCKS ON THE MOVE-Energy firms, Estee Lauder, HMH Holding
Reuters · 04/02 13:12
More
Webull provides a variety of real-time INO stock news. You can receive the latest news about Inovio Pharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About INO
Inovio Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from human papillomavirus (HPV)-related diseases, cancer, and infectious diseases. Its proprietary investigational CELLECTRA devices are designed to deliver the plasmids into the body’s cells for optimal effect, without the use of chemical adjuvants, lipid nanoparticles or viral vectors. Its lead candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease caused by HPV-6 and HPV-11. Its DNA medicines in the pipeline include INO-3112 for the Treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, VGX-3100 for the Treatment of HPV-related Cervical HSIL, VGX-3100 for the Treatment of Anal or Perianal HSIL, INO-5401 for the Treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Prevention of Cancer for People with BRCA1/2 Mutation.